Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nexien BioPharma's share price for the quarter that ended in Mar. 2025 was $0.009. Nexien BioPharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 70.77 Mil. Therefore, Nexien BioPharma's market cap for the quarter that ended in Mar. 2025 was $0.64 Mil.
Nexien BioPharma's quarterly market cap
declined
from Sep. 2024 ($1.23 Mil) to Dec. 2024 ($0.40 Mil) but then
increased
from Dec. 2024 ($0.40 Mil) to Mar. 2025 ($0.64 Mil).
Nexien BioPharma's annual market cap
declined
from Jun. 2022 ($3.78 Mil) to Jun. 2023 ($2.29 Mil) and
declined
from Jun. 2023 ($2.29 Mil) to Jun. 2024 ($1.19 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nexien BioPharma's Enterprise Value for Today is $0.37 Mil.
Nexien BioPharma (OTCPK:NXEN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nexien BioPharma Market Cap Related Terms
Nexien BioPharma Market Cap Historical Data
* Premium members only.
The historical data trend for Nexien BioPharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nexien BioPharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexien BioPharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nexien BioPharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Nexien BioPharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nexien BioPharma's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexien BioPharma (NXEN) has a Market Cap of $0.01 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's Market Cap too high?
Nexien BioPharma's current Market Cap is $0.01 Mil. The Drug Manufacturers industry median Market Cap is 217.83. Nexien BioPharma's value of $0.01 Mil is 100% below this industry median.
How does Nexien BioPharma's Market Cap compare to FLHLF and ZTS?
Nexien BioPharma's Market Cap of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 217.83. Nexien BioPharma's value of $0.01 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 217.83, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexien BioPharma's current Market Cap of $0.01 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nexien BioPharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 217.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexien BioPharma's current Market Cap is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current Market Cap of $0.01 Mil. The current Market Cap is $0.01 Mil and 100% below the Drug Manufacturers industry median of 217.83. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current Market Cap is $0.01 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NXEN has been successfully added to your 